Found: 1443
Select item for more details and to access through your institution.
Is there a relationship between the first-day results of anti-VEGF therapy for macular edema due to vascular diseases and longterm outcomes?
- Published in:
- Arquivos Brasileiros de Oftalmologia, 2024, v. 87, n. 6, p. 1, doi. 10.5935/0004-2749.2022-0228
- By:
- Publication type:
- Article
New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment--a narrative review.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1416555
- By:
- Publication type:
- Article
Acute kidney injury in cancer patients receiving anti-vascular endothelial growth factor monoclonal antibody vs. immune checkpoint inhibitors: a retrospective real-world study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12540-y
- By:
- Publication type:
- Article
Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/ T790M/cis-C797S mutation resistance.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1298389
- By:
- Publication type:
- Article
The matricellular protein CCN5 prevents anti-VEGF drug-induced epithelial-mesenchymal transition of retinal pigment epithelium.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63565-z
- By:
- Publication type:
- Article
Differences between pathologic and non-pathologic high myopia in 4-year outcomes of anti-VEGF therapy for macular neovascularization.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64456-z
- By:
- Publication type:
- Article
Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304782
- By:
- Publication type:
- Article
Treatment burden on patients receiving intravitreal anti‐VEGF for wet age‐related macular degeneration.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, n. 4, p. 478, doi. 10.1111/aos.15783
- By:
- Publication type:
- Article
Prospective, Observational Study of Aflibercept Use in Combination with FOLFIRI in Patients with Metastatic Colorectal Cancer: A Real-World Effectiveness Study.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 1992, doi. 10.3390/cancers16111992
- By:
- Publication type:
- Article
Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC).
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 6, p. 954, doi. 10.1002/psp4.13130
- By:
- Publication type:
- Article
New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study.
- Published in:
- Drug Development Research, 2024, v. 85, n. 4, p. 1, doi. 10.1002/ddr.22218
- By:
- Publication type:
- Article
Treatment of myopic choroidal neovascularization: a network meta-analysis and review.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 6, p. 1693, doi. 10.1007/s00417-023-06271-2
- By:
- Publication type:
- Article
Comparative Study on Anti-VEGF in Wet Age-Related Macular Degeneration in the Setting Based on Lean Methodology from the Bari Intravitreal Injection Registry (BIVIR).
- Published in:
- Ophthalmology & Therapy, 2024, v. 13, n. 6, p. 1619, doi. 10.1007/s40123-024-00927-w
- By:
- Publication type:
- Article
Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice.
- Published in:
- BMC Ophthalmology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12886-024-03491-w
- By:
- Publication type:
- Article
Fruquintinib-induced renal-limited thrombotic microangiopathy: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Anthocyanins in Non-Small Cell Lung Cancer (NSCLC) Treatment and Prevention.
- Published in:
- Nutrients, 2024, v. 16, n. 10, p. 1458, doi. 10.3390/nu16101458
- By:
- Publication type:
- Article
Experts weigh current, future options for AMD management.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 9, p. 1
- By:
- Publication type:
- Article
Vabysmo offers visual improvements in retinal vein occlusion at 72 weeks.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 9, p. 4
- By:
- Publication type:
- Article
Advancements continue in development of retinal disease treatments.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 9, p. 5
- By:
- Publication type:
- Article
With longer-acting therapies, is OCT monitoring advisable between injections?
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 9, p. 11
- By:
- Publication type:
- Article
Prognostic modelling of number of patients with retinal vein occlusion in anti‐VEGF therapy.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, n. 3, p. 318, doi. 10.1111/aos.15721
- By:
- Publication type:
- Article
Anti‐VEGF and steroid combination therapy relative to anti‐VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta‐analysis of safety.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, n. 3, p. e204, doi. 10.1111/aos.15724
- By:
- Publication type:
- Article
Comparability of input parameters in the German Retina.net ROP registry and the EU‐ROP registry – An exemplary comparison between 2011 and 2021.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, n. 3, p. e314, doi. 10.1111/aos.15753
- By:
- Publication type:
- Article
Role of sFlt-1/PlGF Ratio in Diagnosing Preeclampsia.
- Published in:
- American Family Physician, 2024, v. 109, n. 5, p. 470
- By:
- Publication type:
- Article
Tivozanib-induced activation of the mitochondrial apoptotic pathway and suppression of epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
- Published in:
- Korean Journal of Physiology & Pharmacology, 2024, v. 28, n. 3, p. 197, doi. 10.4196/kjpp.2024.28.3.197
- By:
- Publication type:
- Article
Treatment Effects of Switching to Faricimab in Eyes with Diabetic Macular Edema Refractory to Aflibercept.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 5, p. 732, doi. 10.3390/medicina60050732
- By:
- Publication type:
- Article
Macular Neovascularization Secondary to Subclinical Angioid Streaks in Age-Related Macular Degeneration: Treatment Response to Anti-VEGF at 2-Year Follow-up.
- Published in:
- Ophthalmology & Therapy, 2024, v. 13, n. 5, p. 1211, doi. 10.1007/s40123-024-00918-x
- By:
- Publication type:
- Article
4D label-free proteomics analysis of oxygen-induced retinopathy with or without anti-VEGF treatment.
- Published in:
- BMC Genomics, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12864-024-10340-z
- By:
- Publication type:
- Article
Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59632-0
- By:
- Publication type:
- Article
Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration.
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0302295
- By:
- Publication type:
- Article
Hepatocellular carcinoma, vascular endothelial growth factor receptors‐targeting agents, and hypertension: A much more complicated relationship than expected.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1208, doi. 10.1002/cncr.35218
- By:
- Publication type:
- Article
Comparing the efficacy of glucocorticoids and anti-VEGF in treating diabetic macular edema: systematic review and comprehensive analysis.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1342530
- By:
- Publication type:
- Article
Impact of intravitreal anti-VEGF therapy on intraretinal microvascular abnormalities in proliferative diabetic retinopathy.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 4, p. 525, doi. 10.1007/s00592-023-02227-4
- By:
- Publication type:
- Article
nAMD Recurrence Could Be Predicted Using Deep Learning Model.
- Published in:
- American Journal of Managed Care, 2024, v. 30, n. 4, p. 3
- Publication type:
- Article
Antiproliferative Activity of N -Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 892, doi. 10.3390/biomedicines12040892
- By:
- Publication type:
- Article
Sunglasses for Sunlight: Considerations on New Treatment Opportunities for Refractory Colorectal Cancer.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Sodium‐glucose co‐transporter 2 inhibitor therapy reduces the administration frequency of anti‐vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti‐vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1510, doi. 10.1111/dom.15454
- By:
- Publication type:
- Article
Acute aortic catastrophe caused by cardiovascular oncological manipulation by tyrosine kinase inhibitors with immune checkpoint blockades: a case report and literature review.
- Published in:
- European Heart Journal Case Reports, 2024, v. 8, n. 4, p. 1, doi. 10.1093/ehjcr/ytae169
- By:
- Publication type:
- Article
Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 4, p. 1151, doi. 10.1007/s00417-023-06319-3
- By:
- Publication type:
- Article
Real-World Tolerability and Financial Impact of Biosimilar Bevacizumab-awwb Compared With Bevacizumab in Patients With Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 2, p. 70
- By:
- Publication type:
- Article
Immunotherapy Plus VEGF Inhibitor Added to TACE Improves PFS in Unresectable HCC.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 4, p. 13
- Publication type:
- Article
Investigating the Efficacy of EGFR-TKIs and Anti-VEGFR Combination in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1188, doi. 10.3390/cancers16061188
- By:
- Publication type:
- Article
Onco-Hypertension: A Continuously Developing Field between Cancer and Hypertension.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3442, doi. 10.3390/ijms25063442
- By:
- Publication type:
- Article
Vascular Endothelial Growth Factor Inhibitors and the Risk of Aortic Aneurysm and Aortic Dissection.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e240940, doi. 10.1001/jamanetworkopen.2024.0940
- By:
- Publication type:
- Article
Impact of preexisting proteinuria on the development of regorafenib-induced problematic proteinuria in real-world metastatic colorectal cancer treatment.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55727-w
- By:
- Publication type:
- Article
Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 3, p. 252, doi. 10.3390/biom14030252
- By:
- Publication type:
- Article
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 2, p. 375, doi. 10.1007/s10120-023-01455-5
- By:
- Publication type:
- Article
LONGITUDINAL ASSESSMENT OF VISUAL OUTCOMES IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTI-VEGF TREATMENT.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2024, v. 15, n. 3, p. 415
- By:
- Publication type:
- Article
Efficacy of ramucirumab and subsequent nivolumab therapy in patients with advanced gastric cancer: A retrospective study.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 3, p. N.PAG, doi. 10.3892/mco.2024.2715
- By:
- Publication type:
- Article
Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 3, p. 214, doi. 10.1002/phar.2896
- By:
- Publication type:
- Article